NHS to trial innovative cancer blood test
Pharma Times
NOVEMBER 27, 2020
It is hoped that the test will help detect cancer at a much earlier stage
Sat.Nov 21, 2020 - Fri.Nov 27, 2020
159 
Politics, Science and the Remarkable Race for a Coronavirus Vaccine
NY Times
NOVEMBER 21, 2020
The furious race to develop a coronavirus vaccine played out against a presidential election, between a pharmaceutical giant and a biotech upstart, with the stakes as high as they could get.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Digital health player UpHealth swells with three-way merger
pharmaphorum
NOVEMBER 24, 2020
A merger involving two US digital health specialists and a blank cheque company has created a telemedicine player, called UpHealth, that is valued at more than $1.3 billion. The three-way deal combines UpHealth – which provides patient care management, telemedicine and digital pharmacy services and gives its name to the new group – with CloudBreak, which provides a video consultation platform for doctors and patients.
New EU pharma strategy looks to future-proof healthcare sector, stimulate innovation and boost access to biosimilars and generics
Outsourcing Pharma
NOVEMBER 25, 2020
The new EU Pharmaceutical Strategy, adopted today by the European Commission, is designed to improve and accelerate patientsâ access to safe and affordable medicines and address unmet medical needs in the areas of antimicrobial resistance, cancer, and rare diseases.
Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Symkevi/Kalydeco cleared for use in young CF patients
Pharma Times
NOVEMBER 27, 2020
The combination is the first available to treat the underlying cause of CF in this patient group.
AstraZeneca Releases Promising Data on Its Coronavirus Vaccine
NY Times
NOVEMBER 23, 2020
The drug maker said its vaccine candidate was 70 percent effective on average, and potentially up to 90 percent effective, at preventing Covid-19 in an early analysis.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
Bristol Myers Squibb, Noxopharm to partner on immunotherapy pilot
Outsourcing Pharma
NOVEMBER 23, 2020
The pharma giant and the clinical-stage drug developer will join on a pilot study investigating a candidateâs potential in overcoming resistance of a cancer drug.
NICE backs use of new treatment for multiple myeloma
Pharma Times
NOVEMBER 26, 2020
Sanofi's Sarclisa gets the final green light for use by the NHS with funding from the CDF
New patent for Corcept Therap drug KORLYM
Drug Patent Watch
NOVEMBER 27, 2020
Annual Drug Patent Expirations for KORLYM Korlym is a drug marketed by Corcept Therap and is included in one NDA. There are fourteen patents protecting this drug and one Paragraph…. The post New patent for Corcept Therap drug KORLYM appeared first on DrugPatentWatch - Make Better Decisions.
How the rare disease community has developed fertile ground for progress
pharmaphorum
NOVEMBER 27, 2020
Amanda Barrell explores how a perfect storm of changing economics, advances in technology, and the increasing volume of the patient voice is stoking change in the rare disease space. New models of drug development are fuelling life-changing advantages in the rare disease space, previously an economic no-go area for pharma and biotech companies. That was among the discussion points during Fighting Rare Diseases – The Science, Economics and the Patients , a webinar hosted by o2h Group.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Synairgen joins with Parexel Biotech to study COVID-19 drug
Outsourcing Pharma
NOVEMBER 24, 2020
The two companies will collaborate on a Phase III clinical trial investigating a potential treatment for patients hospitalized with COVID-19.
NICE turns down Novartis' Adakveo
Pharma Times
NOVEMBER 27, 2020
Trial results and cost-effectiveness are too uncertain for NHS use, the Institute said
New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR)
Drug Patent Watch
NOVEMBER 25, 2020
Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.
Novartis set to overcome $14 billion patent cliff say analysts
pharmaphorum
NOVEMBER 25, 2020
Novartis’ pipeline is strong enough to overcome a $14 billion patent cliff as blockbuster drugs face generic competition in the coming years, analysts have said. Following a briefing with management, a team of analysts led by Peter Welford said that the big Swiss pharma will be propped up by its psoriasis and infectious diseases blockbuster Cosentyx for some time.
Why Every Small Business Needs an HCM Solution: A Comprehensive Guide
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Ad Council’s Challenge: Persuade Skeptics to Believe in Covid Vaccines
NY Times
NOVEMBER 22, 2020
The nonprofit marketing group led a polio vaccine campaign in the 1950s. Now it is working on a $50 million ad blitz to counter concerns about coming treatments.
COVID-19 pandemic has emphasised existing health inequalities, research finds
Pharma Times
NOVEMBER 25, 2020
New report conducted by Imperial College London researchers and Philips UK highlights issues within the NHS
New patent expiration for Janssen Pharms drug RISPERDAL CONSTA
Drug Patent Watch
NOVEMBER 24, 2020
Annual Drug Patent Expirations for RISPERDAL+CONSTA Risperdal Consta is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…. The post New patent expiration for Janssen Pharms drug RISPERDAL CONSTA appeared first on DrugPatentWatch - Make Better Decisions.
Thriving in COVID-19 with flexible marketing strategies
pharmaphorum
NOVEMBER 24, 2020
Pharma sales is set to change forever. To keep afloat in the current climate, teams need to embrace flexibility and remember that traditional content won’t work in new contexts, say experts from Syneos Health. Selling in a socially-distanced world is about more than simply taking conversations online – it requires a wholesale change in how sales teams operate and the kinds of content they use.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA grants EUA for combo COVID-19 treatment
Outsourcing Pharma
NOVEMBER 23, 2020
The agency has given the go-ahead for use of baricitinib in conjunction with remdesivir for treating patients hospitalized with severe cases of the virus.
Moderna signs deal with EU for 160 million COVID-19 vaccine doses
Pharma Times
NOVEMBER 26, 2020
Delivery of vaccine doses to EU could begin by early 2021
New patent expiration for Ucb Inc drug NEUPRO
Drug Patent Watch
NOVEMBER 26, 2020
Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents…. The post New patent expiration for Ucb Inc drug NEUPRO appeared first on DrugPatentWatch - Make Better Decisions.
The calm after the storm: How COVID-19 is making pharma more resilient
pharmaphorum
NOVEMBER 26, 2020
COVID-19 is proving to be the perfect storm in terms of the supply of pharmaceutical products. But learning how to overcome the challenges of 2020 will serve the industry well for years to come. As part of our EU Leader series, Christian Pawlu, head of strategy, portfolio and BD&L at Sandoz, told us about how securing supply in a time of crisis will ensure future access, build resilience, and transform relationships.
Best Practices to Streamline Compensation Management: A Foundation for Growth
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Ad Council’s Challenge: Persuade Skeptics to Believe in Covid Vaccines
NY Times
NOVEMBER 22, 2020
The nonprofit marketing group led a polio vaccine campaign in the 1950s. Now it is working on a $50 million ad blitz to counter concerns about coming treatments.
EU to review Merck's targeted lung cancer drug
Pharma Times
NOVEMBER 27, 2020
Tepotinib could be the first treatment on the market for NSCLC in adults harbouring METex14 skipping alterations
Scottish biotech outfit launches clinical trials division
Outsourcing Pharma
NOVEMBER 24, 2020
Intelligent Tissue Group has launched its Intelligent Clinical trials facility to help assess the effectiveness and safety of potential new treatments.
Russian Sputnik COVID-19 vaccine ‘will cost less than $10 a dose’
pharmaphorum
NOVEMBER 24, 2020
The developer of Russia’s COVID-19 vaccine Sputnik V has pledged to make it available for less than $10 per dose – or $20 per two-dose course – on the same day as revealing new clinical data with the shot. Sputnik V ’s efficacy has remained high at 91.4% according to the latest analysis, which comes from almost 19,000 subjects who were assessed seven days after the second dose of the vaccine, administered 28 days after the first.
Enhance Healthcare Efficiency With Top Payroll & HCM Services
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Política, ciencia y la carrera vertiginosa para encontrar una vacuna contra el coronavirus
NY Times
NOVEMBER 23, 2020
El desarrollo veloz de una vacuna contra la COVID-19 sucedió durante una elección presidencial y entre un gigante farmacéutico y una pequeña empresa recién llegada de la biotecnología. Las apuestas eran muy altas.
BMS inks drug discovery deal with Schrödinger
Pharma Times
NOVEMBER 25, 2020
Deal will focus on developing small molecules against a number of diseases
New patent expiration for Novartis drug FORADIL
Drug Patent Watch
NOVEMBER 27, 2020
Annual Drug Patent Expirations for FORADIL Foradil is a drug marketed by Novartis and is included in two NDAs. There is one patent protecting this drug. This drug has twenty-eight…. The post New patent expiration for Novartis drug FORADIL appeared first on DrugPatentWatch - Make Better Decisions.
Brexit could hinder access to coronavirus vaccines, says pharma group
pharmaphorum
NOVEMBER 26, 2020
The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other measures in this week’s spending review aimed at reviving the economy after the pandemic. In the build-up to chancellor Rishi Sunak’s announcement in the House of Commons, the Association of the British Pharmaceutical Industry (ABPI) chief executive Richard Torbett warned that a no-deal Brexit could disrupt supplies of vaccines.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Let's personalize your content